Jie Zhang

10PUBLICATIONS
63CO-AUTHORS
Data mining and knowledge discoveryMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Mechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 22, 2025
PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancers.

Ying He, Wei Li, Meiling Zhang

|Mar 09, 2024
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.

Cang Li, Zhengyu Wang, Licheng Yao

|Sep 10, 2020
Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade.

Liangliang Wang, Yan Gao, Gao Zhang

|Mar 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.

Shujing Liu, Gao Zhang, Jianping Guo

Pageof 2